Condition
High Grade B-Cell Lymphoma, Not Otherwise Specified clinical trials and research
As of November 12, 2026, Find a Trial lists 6 High Grade B-Cell Lymphoma, Not Otherwise Specified clinical trials that are recruiting, at sites in 3 countries (most in United States (4), Australia (1), Spain (1)). By phase: Phase 1/2 (2), Phase 1 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest High Grade B-Cell Lymphoma, Not Otherwise Specified clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Glofitamab with R-CHOP for Newly Diagnosed HIV-Related Large B-Cell Lymphoma | Phase 1 | Rockville, Maryland | Recruiting | Jun 16, 2026 |
| Epcoritamab plus dose‑adjusted EPOCH‑R for aggressive B‑cell lymphoma | Phase 2 | Seattle, Washington | Recruiting | Jul 31, 2025 |
| Treatment for relapsed or refractory B-cell lymphoma using SynKIR-310 | Phase 1 | Denver, Colorado and 4 other locations | Recruiting | Aug 9, 2024 |
| Combination therapy with Epcoritamab for relapsed aggressive B-cell lymphoma | Phase 2 | Melbourne, Victoria | Recruiting | Mar 1, 2024 |
| Testing IDP-121 in patients with certain blood cancers | Phase 1/2 | Santander, Cantabria and 10 other locations | Recruiting | Jun 18, 2023 |
| Using inotuzumab ozogamicin with chemotherapy to treat acute lymphoblastic leukemia | Phase 1/2 | Houston, Texas | Recruiting | Jun 13, 2011 |
All recruiting trials (6)
-
Glofitamab with R-CHOP for Newly Diagnosed HIV-Related Large B-Cell Lymphoma
This phase 1 study tests glofitamab plus R-CHOP chemoimmunotherapy in adults newly diagnosed with HIV-related large B-cell lymphoma to see if the regimen is safe and tolerable.
-
Epcoritamab plus dose‑adjusted EPOCH‑R for aggressive B‑cell lymphoma
This trial tests whether adding epcoritamab to dose‑adjusted EPOCH‑R chemotherapy can safely improve outcomes for adults with untreated aggressive B‑cell non‑Hodgkin lymphoma.
-
Treatment for relapsed or refractory B-cell lymphoma using SynKIR-310
This study is testing a new treatment called SynKIR-310 to see if it can help adults with relapsed or refractory B-cell lymphoma feel better.
-
Combination therapy with Epcoritamab for relapsed aggressive B-cell lymphoma
This study is testing if adding Epcoritamab to chemotherapy helps people with relapsed aggressive B-cell lymphoma get better before a stem cell transplant and live longer without the disease coming back.
-
Testing IDP-121 in patients with certain blood cancers
This study is testing a new treatment called IDP-121 to see if it can help people with certain blood cancers, like multiple myeloma and lymphoma, feel better and live longer.
-
Using inotuzumab ozogamicin with chemotherapy to treat acute lymphoblastic leukemia
This study is testing if a new drug combined with lighter chemotherapy can help older patients with acute lymphoblastic leukemia who can't handle stronger treatments.
Related topics
Quick answers
How many High Grade B-Cell Lymphoma, Not Otherwise Specified clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), Australia (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.